Igor Bilinsky Insider Profile

4 Followers
Igor Bilinsky, Sr VP, Corporate Development at Fresh Tracks Therapeutics, holds 193.80K shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds ― shares in Tecogen (Ticker: TGEN), holds ― shares in Oncternal Therapeutics (Ticker: ONCT).
tipranks
Igor Bilinsky

Igor Bilinsky
Fresh Tracks Therapeutics (FRTX)
Sr VP, Corporate Development

Not Ranked
Igor Bilinsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$734K
80.47%
19.53%
0.00%
0.00%
A breakdown of Igor Bilinsky's holdings

Insider Roles

Iovance Biotherapeutics
(IOVA)
COO
Fresh Tracks Therapeutics
(FRTX)
Sr VP, Corporate Development
Tecogen
(TGEN)
Chief Operating Officer
Oncternal Therapeutics
(ONCT)
CBO
Roles that Igor Bilinsky holds in companies

Most Profitable Insider Trade

Stock:
Fresh Tracks Therapeutics
(FRTX)
Rating:Informative Buy
Date:Jan 14, 2014 - Jan 14, 2015
Return:-26.40%
The most profitable trade made by Igor Bilinsky

Igor Bilinsky's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fresh Tracks Therapeutics
Jul 15, 2015
Sr VP, Corporate Development
Uninformative Sell
868.02
$143.41K
Tecogen
Chief Operating Officer
Oncternal Therapeutics
CBO
Iovance Biotherapeutics
Oct 16, 2024
COO
Uninformative Buy
13.53K
$590.72K
~RXDX
Ignyta Inc
Jan 11, 2016
Uninformative Buy
$187.57K
List of latest transactions for each holding click on a transaction to see Igor Bilinsky's performance on stock

Igor Bilinsky insider profile FAQ

What is the percentage of profitable transactions made by Igor Bilinsky?
The percentage of profitable transactions made by Igor Bilinsky is ―.
    What is the average return per transaction made by Igor Bilinsky?
    The average return per transaction made by Igor Bilinsky is ―.
      What stocks does Igor Bilinsky hold?
      Igor Bilinsky holds: FRTX, TGEN, ONCT, IOVA, ~RXDX stocks.
        What was Igor Bilinsky’s latest transaction?
        Igor Bilinsky latest transaction was an Uninformative Sell of $868.02.
          What was Igor Bilinsky's most profitable transaction?
          Igor Bilinsky’s most profitable transaction was an Informative Buy of FRTX stock on January 14, 2014. The return on the trade was -26.40%.
            What is Igor Bilinsky's role in Fresh Tracks Therapeutics?
            Igor Bilinsky's role in Fresh Tracks Therapeutics is Sr VP, Corporate Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.